Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion
Bitget2026/10/21 10:04- Elevance Health’s third-quarter 2026 diluted earnings rose 18% year over year to $6.27 per share.
- Operating revenue increased year over year to $50.44 billion, supported by higher premium yields, CarelonRx product revenue and service fees.
- Health Benefits operating gain fell 27% year over year to $436 million, reflecting targeted investments supporting its long-term operating model.
- The full-year 2026 outlook calls for diluted earnings of at least $22 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Synthetix Protocol DAO transfers 428,000 stolen SNX
Is cutting AI spending more beneficial? Bank of America gives a counterintuitive judgment: although “unpopular,” it may extend the economic cycle, and chip stocks could enjoy a longer profit runway.
Bank of America: Chip companies cutting capital expenditures may be “unpopular,” but it could extend the earnings cycle.
How will US stocks move after the midterm elections? Wolfe warns of a "wall of worry" about AI, while Morgan Stanley says the correction is nearing its end.
The "wall of worry" surrounding AI stands in the way, with Nvidia’s earnings report and oil prices becoming key variables.
Yen loses ground to the Dollar despite US-Iran deal hopes
Crypto prices
More
